Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 0.57 1.59% 0.01
BOLT closed up 1.59 percent on Wednesday, November 20, 2024, on 42 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish 1.59%
Stochastic Buy Signal Bullish 1.59%
Doji - Bullish? Reversal 1.59%
Lower Bollinger Band Walk Weakness 1.59%
New 52 Week Low Weakness 1.59%
Outside Day Range Expansion 1.59%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 19 hours ago
Up 3% about 21 hours ago
Up 2% about 21 hours ago
Up 1% about 21 hours ago
60 Minute Opening Range Breakout about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Tumor Pharmaceutical Products Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu

Is BOLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.56
52 Week Low 0.54
Average Volume 139,072
200-Day Moving Average 0.86
50-Day Moving Average 0.63
20-Day Moving Average 0.63
10-Day Moving Average 0.61
Average True Range 0.04
RSI (14) 33.77
ADX 20.39
+DI 9.59
-DI 23.14
Chandelier Exit (Long, 3 ATRs) 0.61
Chandelier Exit (Short, 3 ATRs) 0.65
Upper Bollinger Bands 0.71
Lower Bollinger Band 0.56
Percent B (%b) 0.09
BandWidth 24.07
MACD Line -0.02
MACD Signal Line -0.01
MACD Histogram -0.0103
Fundamentals Value
Market Cap 21.64 Million
Num Shares 38 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 5.68
Price-to-Book 0.31
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.62
Resistance 3 (R3) 0.62 0.61 0.61
Resistance 2 (R2) 0.61 0.59 0.61 0.61
Resistance 1 (R1) 0.59 0.58 0.60 0.59 0.61
Pivot Point 0.57 0.57 0.58 0.57 0.57
Support 1 (S1) 0.55 0.56 0.56 0.55 0.53
Support 2 (S2) 0.54 0.55 0.54 0.53
Support 3 (S3) 0.52 0.54 0.53
Support 4 (S4) 0.52